Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
RemeGen and Innovent Collaborate on Clinical Trials to Evaluate the Potential of RC88 and RC108 Combined with PD-1 Therapy for Advanced Solid Tumors
2023-07-10 10:24
Kexing Biopharm Makes it into China's Top 20 Biopharmaceutical Enterprises (Blood Products, Vaccines and Insulin) for Two Consecutive Years
2023-07-07 19:43
Transcenta Received Approvals from China CDE and South Korea MFDS to Initiate TranStar 301 Global Phase III Pivotal Trial of Osemitamab (TST001)
2023-07-07 15:52
MGI's DNBSEQ-T7* Receives Approval for Clinical Use in South Korea
2023-07-06 09:00
Brii Biosciences Broadens its Leadership in Hepatitis B with a Portfolio Now Addressing Disease's Burdens from Prevention to Cure
2023-07-06 07:25
Brii Biosciences Provides Latest Clinical Development and Corporate Updates
2023-07-06 07:19
Sirnaomics Establishes a Strategic Partnership with EDIRNA Inc., an RNA-Editing Therapeutic Company
2023-07-05 23:07
apoQlar secures funding led by YZR Capital, revolutionizes surgical care through partnerships
2023-07-05 13:00
GILEAD SCIENCES AND IAS - THE INTERNATIONAL AIDS SOCIETY - HONOUR HEALTHCARE PROVIDERS GLOBALLY WHO CHAMPION STIGMA-FREE HIV SERVICES
2023-07-05 11:00
VentureBlick Secures US$2.6M for First Two Startups, Unveils Super Incubator Model for Medtech Innovation
2023-07-05 10:00
Chula Researchers Find "Extreme Stress and Depression" Chemicals in Sweat and Successfully Test Firefighters' Mental Health for the First Time!
2023-07-04 16:59
PharmaLedger Reaches 30+ Members Demonstrating the Ecosystem Trend in Digital Health
2023-07-04 10:30
AFTER FIVE YEARS OF SUCCESSFUL EXPERIENCE INTERNATIONALLY, BIOCON BIOLOGICS' HULIO® BIOSIMILAR TO HUMIRA®, NOW AVAILABLE IN THE UNITED STATES
2023-07-04 01:22
Lumos Receives US FDA Clearance for FebriDx®
2023-07-03 21:50
Henlius Forecasts Profit in 1H 2023
2023-07-03 18:59
Singapore Hosts the 25th World Congress of Dermatology - The First in Southeast Asia, Drawing Over 11,000 Delegates to Discuss New Developments in Skin Research and Treatments
2023-07-03 18:29
SHL Medical acquires 100% of the shares in Swiss company LCA Automation
2023-07-03 17:00
Alma, a Sisram Medical company, is establishing a direct operation in China after completing the acquisition of PhotonMed
2023-07-03 15:48
Fair Play Menarini International Awards, the 2023 edition starts with the talk show "The Champions tell their Stories" in Piazza della Signoria, Florence
2023-07-03 09:31
Innovent and IASO Bio Announce the NMPA Approval of FUCASO®, the First Fully-human BCMA CAR-T Therapy, for the Treatment of Relapsed or Refractory Multiple Myeloma
2023-07-03 08:00
1
99
100
101
102
103
532